Skip to content

Released Aug 4, 2025, after the close

10-Q filed Aug 5, 2025, 36 days after period end · 0001653477-25-000108

Q2 2025 · 10-Q
Revenue$331.50M−15.1% vs Q2 2024+33.7% vs Q1 2025
Net Income-$146.50MN/M vs Q2 2024N/M vs Q1 2025
EPS Diluted-$4.02N/M vs Q2 2024N/M vs Q1 2025
Gross Profit$127,800,000+3.7%
Operating Cash Flowderived$79,000,000+166.0%
Free Cash Flowderived$66,800,000+475.9%
Margins · derived
Gross margin38.6%+7.0 pt vs Q2 2024
Net margin-44.2%+28.4 pt vs Q2 2024

What the release said

The release

Same quarter

MetricQ2 2025Q2 2024Q2 2023Q2 2022
Revenue$331.50M$390.60M$481.80M$419.90M
Net Income-$146.50M-$283.70M$35.50M$59.80M
EPS Diluted-$4.02-$7.81$0.97$1.54

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR